Jun 14, 2021
A group of the world's richest nations vowed Sunday to collectively donate at least 1 billion coronavirus vaccine doses to developing nations over the next year, but a closer look reveals that the pledge includes just 613 million new doses--a paltry sum compared to the 11 billion doses that experts say will be needed to inoculate 70% of the global population.
"The G7 response to the scale of the challenge is just embarrassing."
--Heidi Chow, Global Justice Now
Bloomberg's Josh Wingrove and Alberto Nardelli reported that in order to reach the promised 1 billion-dose figure, G7 leaders "included pledges made starting back in February."
"So far, the G7 countries have promised 613 million truly new doses--including some funded in part by previously announced aid," Wingrove and Nardelli noted. "If doses already announced in recent weeks by G7 and E.U. nations are included, the tally grows to roughly 870 million doses."
"The 500 million doses pledged by the U.S. will be funded in part by $2 billion that Biden had initially promised for Covax, the World Health Organization-backed initiative aimed at facilitating equitable global distribution. Biden will claw that money back and buy doses directly, then work with Covax to distribute them," the pair continued. "The Canadian pledge includes 13 million directly donated doses as well as a previously announced C$440 million ($361.9 million) pledge to Covax. Counting that money, Canada framed its donation as up to 100 million doses total, though only the 13 million are new."
Already outraged by the inadequacy of the 1 billion-dose commitment--which, if fulfilled, would provide enough shots to protect just 11% of the world's unvaccinated population--public health campaigners said the G7 countries' inflation of their pledge with older promises further underscores the failure of the closely watched summit in Cornwall, England over the weekend. The gathering took place as developing nations in Africa, South America, and Asia are experiencing deadly Covid-19 waves as they struggle to get their vaccination campaigns off the ground.
"Donations were never going to be enough, but the 1 billion doses promised by the G7 turns out to be just 613 million new doses and some through clawed back Covax financial donations," said Heidi Chow, senior policy and campaigns manager with the U.K.-based advocacy group Global Justice Now. "The G7 response to the scale of the challenge is just embarrassing."
Global Justice Now's director Nick Dearden echoed that message early Monday, tweeting that "G7 leaders went to Cornwall and all the world got was 600 million truly new vaccine doses."
"A single factory could produce this number in a year if you waived patents," Dearden added.
\u201cActions speak louder than words.\n\nG7 leaders said they want to vaccinate the world by the end of next year, but the #G7Summit showed they care more about protecting the monopolies and patents of pharmaceutical giants.\u201d— The People's Vaccine (@The People's Vaccine) 1623657145
The G7 summit came amid ongoing negotiations over India and South Africa's patent waiver proposal at the World Trade Organization. While the waiver is backed by more than 100 countries, the opposition of a small group of wealthy nations has prevented approval of the measure, which would temporarily lift intellectual property barriers that are stopping manufacturers around the world from producing generic vaccines.
The U.S. and France are the only two G7 nations that have endorsed the patent waiver.
"Dose-sharing is part of the solution if done immediately, but charity is not going to fix the colossal vaccine supply crisis," said Anna Marriott, health policy manager at Oxfam International. "In order to ramp up production, the G7 should break the pharmaceutical monopolies and insist that the vaccine science and know-how is shared with qualified manufacturers around the world."
"The lives of millions of people in developing countries should never be dependent on the good will of rich nations and profit-hungry pharmaceutical corporations," Marriott added.
Join Us: News for people demanding a better world
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A group of the world's richest nations vowed Sunday to collectively donate at least 1 billion coronavirus vaccine doses to developing nations over the next year, but a closer look reveals that the pledge includes just 613 million new doses--a paltry sum compared to the 11 billion doses that experts say will be needed to inoculate 70% of the global population.
"The G7 response to the scale of the challenge is just embarrassing."
--Heidi Chow, Global Justice Now
Bloomberg's Josh Wingrove and Alberto Nardelli reported that in order to reach the promised 1 billion-dose figure, G7 leaders "included pledges made starting back in February."
"So far, the G7 countries have promised 613 million truly new doses--including some funded in part by previously announced aid," Wingrove and Nardelli noted. "If doses already announced in recent weeks by G7 and E.U. nations are included, the tally grows to roughly 870 million doses."
"The 500 million doses pledged by the U.S. will be funded in part by $2 billion that Biden had initially promised for Covax, the World Health Organization-backed initiative aimed at facilitating equitable global distribution. Biden will claw that money back and buy doses directly, then work with Covax to distribute them," the pair continued. "The Canadian pledge includes 13 million directly donated doses as well as a previously announced C$440 million ($361.9 million) pledge to Covax. Counting that money, Canada framed its donation as up to 100 million doses total, though only the 13 million are new."
Already outraged by the inadequacy of the 1 billion-dose commitment--which, if fulfilled, would provide enough shots to protect just 11% of the world's unvaccinated population--public health campaigners said the G7 countries' inflation of their pledge with older promises further underscores the failure of the closely watched summit in Cornwall, England over the weekend. The gathering took place as developing nations in Africa, South America, and Asia are experiencing deadly Covid-19 waves as they struggle to get their vaccination campaigns off the ground.
"Donations were never going to be enough, but the 1 billion doses promised by the G7 turns out to be just 613 million new doses and some through clawed back Covax financial donations," said Heidi Chow, senior policy and campaigns manager with the U.K.-based advocacy group Global Justice Now. "The G7 response to the scale of the challenge is just embarrassing."
Global Justice Now's director Nick Dearden echoed that message early Monday, tweeting that "G7 leaders went to Cornwall and all the world got was 600 million truly new vaccine doses."
"A single factory could produce this number in a year if you waived patents," Dearden added.
\u201cActions speak louder than words.\n\nG7 leaders said they want to vaccinate the world by the end of next year, but the #G7Summit showed they care more about protecting the monopolies and patents of pharmaceutical giants.\u201d— The People's Vaccine (@The People's Vaccine) 1623657145
The G7 summit came amid ongoing negotiations over India and South Africa's patent waiver proposal at the World Trade Organization. While the waiver is backed by more than 100 countries, the opposition of a small group of wealthy nations has prevented approval of the measure, which would temporarily lift intellectual property barriers that are stopping manufacturers around the world from producing generic vaccines.
The U.S. and France are the only two G7 nations that have endorsed the patent waiver.
"Dose-sharing is part of the solution if done immediately, but charity is not going to fix the colossal vaccine supply crisis," said Anna Marriott, health policy manager at Oxfam International. "In order to ramp up production, the G7 should break the pharmaceutical monopolies and insist that the vaccine science and know-how is shared with qualified manufacturers around the world."
"The lives of millions of people in developing countries should never be dependent on the good will of rich nations and profit-hungry pharmaceutical corporations," Marriott added.
A group of the world's richest nations vowed Sunday to collectively donate at least 1 billion coronavirus vaccine doses to developing nations over the next year, but a closer look reveals that the pledge includes just 613 million new doses--a paltry sum compared to the 11 billion doses that experts say will be needed to inoculate 70% of the global population.
"The G7 response to the scale of the challenge is just embarrassing."
--Heidi Chow, Global Justice Now
Bloomberg's Josh Wingrove and Alberto Nardelli reported that in order to reach the promised 1 billion-dose figure, G7 leaders "included pledges made starting back in February."
"So far, the G7 countries have promised 613 million truly new doses--including some funded in part by previously announced aid," Wingrove and Nardelli noted. "If doses already announced in recent weeks by G7 and E.U. nations are included, the tally grows to roughly 870 million doses."
"The 500 million doses pledged by the U.S. will be funded in part by $2 billion that Biden had initially promised for Covax, the World Health Organization-backed initiative aimed at facilitating equitable global distribution. Biden will claw that money back and buy doses directly, then work with Covax to distribute them," the pair continued. "The Canadian pledge includes 13 million directly donated doses as well as a previously announced C$440 million ($361.9 million) pledge to Covax. Counting that money, Canada framed its donation as up to 100 million doses total, though only the 13 million are new."
Already outraged by the inadequacy of the 1 billion-dose commitment--which, if fulfilled, would provide enough shots to protect just 11% of the world's unvaccinated population--public health campaigners said the G7 countries' inflation of their pledge with older promises further underscores the failure of the closely watched summit in Cornwall, England over the weekend. The gathering took place as developing nations in Africa, South America, and Asia are experiencing deadly Covid-19 waves as they struggle to get their vaccination campaigns off the ground.
"Donations were never going to be enough, but the 1 billion doses promised by the G7 turns out to be just 613 million new doses and some through clawed back Covax financial donations," said Heidi Chow, senior policy and campaigns manager with the U.K.-based advocacy group Global Justice Now. "The G7 response to the scale of the challenge is just embarrassing."
Global Justice Now's director Nick Dearden echoed that message early Monday, tweeting that "G7 leaders went to Cornwall and all the world got was 600 million truly new vaccine doses."
"A single factory could produce this number in a year if you waived patents," Dearden added.
\u201cActions speak louder than words.\n\nG7 leaders said they want to vaccinate the world by the end of next year, but the #G7Summit showed they care more about protecting the monopolies and patents of pharmaceutical giants.\u201d— The People's Vaccine (@The People's Vaccine) 1623657145
The G7 summit came amid ongoing negotiations over India and South Africa's patent waiver proposal at the World Trade Organization. While the waiver is backed by more than 100 countries, the opposition of a small group of wealthy nations has prevented approval of the measure, which would temporarily lift intellectual property barriers that are stopping manufacturers around the world from producing generic vaccines.
The U.S. and France are the only two G7 nations that have endorsed the patent waiver.
"Dose-sharing is part of the solution if done immediately, but charity is not going to fix the colossal vaccine supply crisis," said Anna Marriott, health policy manager at Oxfam International. "In order to ramp up production, the G7 should break the pharmaceutical monopolies and insist that the vaccine science and know-how is shared with qualified manufacturers around the world."
"The lives of millions of people in developing countries should never be dependent on the good will of rich nations and profit-hungry pharmaceutical corporations," Marriott added.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.